Evidence map›Paper›PMID 40882614›Full record

ArticleJMIR public health and surveillance2025

SARS-CoV-2 Antibody Prevalence Across Unvaccinated Health Care Workers During the COVID-19 Pandemic in Yemen: Cross-Sectional Study.

Eihab Al-Herwi, Maryam Baras, Khadega Alhetar, Mohammed A Farhan, Rashad M Saleh, Amani As-Suhbani, Manal Alshoaibi, Mansour Mohammed, Zainab Morshed, Asia Shujaa-Aldeen and 4 more

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eihab Al-HerwiMedical Laboratories Department, Faculty of Medicine and Health Sciences, Ibb University, University Street, Ibb, 22017, Yemen, 967 0778811234.ORCID 0009-0000-7077-7403
Maryam BarasNational Centre of Public Health Laboratories, Al-Mukalla, Yemen.ORCID 0000-0002-1747-3088
Khadega AlhetarMedical Laboratories Department, Faculty of Medicine and Health Sciences, Ibb University, University Street, Ibb, 22017, Yemen, 967 0778811234.ORCID 0009-0006-4443-104X
Mohammed A FarhanMedical Laboratories Department, Faculty of Medicine and Health Sciences, Ibb University, University Street, Ibb, 22017, Yemen, 967 0778811234.ORCID 0000-0002-4577-7740
Rashad M SalehMedical Laboratories Department, Faculty of Medicine and Health Sciences, Ibb University, University Street, Ibb, 22017, Yemen, 967 0778811234.ORCID 0000-0003-4427-249X
Amani As-SuhbaniMedical Laboratories Department, Faculty of Medicine and Health Sciences, Ibb University, University Street, Ibb, 22017, Yemen, 967 0778811234.ORCID 0009-0006-9059-283X
Manal AlshoaibiNational Centre of Public Health Laboratories, Ibb, Yemen.ORCID 0009-0008-7034-3734
Mansour MohammedMedical Microbiology, Ibb University, Ibb, Yemen.ORCID 0009-0003-0563-2787
Zainab MorshedMedical Microbiology, Ibb University, Ibb, Yemen.ORCID 0009-0004-3551-5896
Asia Shujaa-AldeenMedical Laboratories, International Malaysian University, Ibb, Yemen.ORCID 0009-0001-1919-244X
Fatima GhanemMedical Laboratories, International Malaysian University, Ibb, Yemen.ORCID 0009-0001-0417-4097
Bra'ah AlQisiMedical Laboratories, International Malaysian University, Ibb, Yemen.ORCID 0009-0009-7586-8684
Mohammed AlherwiPharmacy Department, University of Science and Technology, Ibb, Yemen.ORCID 0009-0000-6814-659X
Tony BrunsDepartment of Internal Medicine III, University Hospital Rheinisch-Westfälische Technische Hochschule, Aachen, Germany.ORCID 0000-0002-5576-6914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic presented significant challenges to health care centers across Yemen. The lack of access to COVID-19 vaccines and limited availability of personal protective equipment greatly increased the risk of SARS-CoV-2 exposure among health care workers (HCWs). Only a few studies have examined the seroprevalence and burden of SARS-CoV-2 among Yemeni HCWs. Objective: This study aimed to assess the seroprevalence of SARS-CoV-2 and associated risk factors among a cohort of unvaccinated HCWs in Ibb City, the capital of Ibb Governorate, located in the highlands of southwestern Yemen between July 2022 and January 2023. Methods: Unvaccinated HCWs employed in public and private hospitals, dispensaries, pharmacies, and laboratories in Ibb City during the past 6 months were eligible. Blood samples, occupational information, and structured interviews using a questionnaire were collected from a convenience sample of 396 unvaccinated HCWs actively providing health care services between July 2022 and January 2023. SARS-CoV-2 antibody presence was determined using a lateral flow immunoassay. Results: Of the 396 HCWs tested, 268 (67.7%) were positive for SARS-CoV-2 antibodies, with no significant difference in seropositivity between sex (P=.29). Key factors associated with seropositivity included occupation and workplace. Compared to laboratory technicians (76/124, 61%), nurses (93/124, 75%; odds ratio [OR] 1.89, 95% CI 1.10-3.26; P=.02) and physician assistants (13/14, 92.9%; OR 8.21, 95% CI 1.04-64.79; P=.046) had significantly higher odds of seropositivity. Similarly, working in hospitals was associated with significantly higher odds of seropositivity compared to working in laboratories (OR 2.77, 95% CI 1.59-4.81; P<.001). Overall, 82% (219/268) of seropositive HCWs reported COVID-19-related symptoms within the last 6 months (OR 3.82, 95% CI 2.40-6.09; P<.001), the majority being fever (191/256, 74.6%; OR 2.40, 95% CI 1.56-3.72; P<.001), headache (175/230, 76.1%; OR 2.50, 95% CI 1.62-3.84; P<.001), cough (162/205, 79%; OR 3.02, 95% CI 1.94-4.70; P<.001), or loss of taste (155/202, 76.7%; OR 2.36, 95% CI 1.53-3.65; P<.001) or smell (146/191, 76.4%; OR 2.21, 95% CI 1.43-3.41; P<.001). Conclusions: This study reveals a high prevalence of SARS-CoV-2 antibodies among HCWs in Ibb City, Yemen, underscoring the impact of limited vaccination and personal protective equipment availability in 2022 and 2023. These findings highlight the urgent need for improved protective measures and vaccination efforts in conflict-affected regions.

Indexed as

Antibodies, ViralCOVID-19Health PersonnelSARS-CoV-2AdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPandemicsPrevalenceRisk FactorsSeroepidemiologic StudiesYemenAntibodies, ViralCOVID-19health care workersrisk factorsSARS-CoV-2 antibodiesYemen

Identifiers

PMID40882614
PMCPMC12396825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.